CPL today announced the appointment of Joe Troxell as Chief Executive Officer.
Joe brings deep leadership experience in contract development and manufacturing, and regulated pharmaceutical environments, with a strong track record of driving operational performance, scaling organizations, and executing growth strategies aligned with customer and investor objectives. As CEO, Joe will lead CPL’s strategic direction with a focus on profitable growth, disciplined capital deployment, and long-term value creation for our growing customer base.
Under Joe’s leadership, CPL will continue to strengthen its position as one of North America’s leading CDMOs focused on non-sterile liquid and semi-solid dosage forms, while investing in capabilities, systems, and talent to support sustainable growth and operational excellence.
Joe’s appointment reflects CPL’s commitment to outstanding customer service, strong governance, and execution against its strategic and financial objectives.
About CPL
CPL is one of the leading North American contract development and manufacturing organizations (CDMOs) specializing in non-sterile liquid and semi-solid dosage forms, providing development through commercial manufacturing services to pharmaceutical and consumer health companies worldwide.